Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Prostate Cancer
ZERO Outraged Docs Don't Offer Solution in PSA Crisis
March 31st, 2009
A new study of the effectiveness of the PSA test for prostate cancer is yet another claim prostate cancer screening has little to no value in lowering the death rate with offering no solutions to the problem. While this most recent study, published in the New England Journal of Medicine, casts a blanket statement about prostate cancer screening, it fails to address those individuals who are in high risk groups like African-Americans and those with a family history of the disease as well as those men who will have rapidly growing tumors. The patient advocate community stands together in calling for immediate increases in prostate cancer research...
Source: Cancer Weekly (2009-03-31)
|
